Answers are grounded in this paper and cite their sources.
Delayed treatment effects on time-to-event outcomes are commonly observed in randomized controlled trials of cancer immunotherapies. When the treatment effect has a delayed onset, the conventional test/estimation approach-using the log-rank test for between-group comparison and Cox's hazard ratio to quantify the treatment effect-can be suboptimal. The log-rank test may lack power in such scenarios, and the interpretation of the hazard ratio is often ambiguous. Recently, alternative test/estimation approaches have been proposed to address these limitations. One such approach is based on long-term restricted mean survival time (LT-RMST), while another is based on average hazard with survival weight (AH-SW). This paper integrates these two concepts and introduces a novel long-term average hazard (LT-AH) approach with survival weight for both hypothesis testing and estimation. Numerical studies highlight specific scenarios where the proposed LT-AH method achieves higher power than the existing alternatives. The LT-AH for each group can be estimated nonparametrically, and the proposed between-group comparison maintains test/estimation coherency. Because the difference and ratio of LT-AH do not rely on model assumptions about the relationship between two groups, the LT-AH approach provides a robust framework for estimating the magnitude of between-group differences. Furthermore, LT-AH allows for treatment effect quantification in both absolute (difference in LT-AH) and relative (ratio of LT-AH) terms, aligning with guideline recommendations and addressing practical needs. Given its interpretability and improved power in certain settings, the proposed LT-AH approach offers a useful alternative to conventional hazard-based methods, particularly when delayed treatment effects are expected.
No takes yet. Share an insight, caveat, or question.
Horiguchi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: